Adiponectin is associated with poor prognosis in carcinoma patients: evidence from a meta-analysis

Background Studies have come to conflicting conclusions about whether adiponectin (APN) expression is associated with cancer prognosis. To help resolve this question, we meta-analyzed the available evidence.